Israeli -
Kiebrania -
Ministry of Health
endoscopy systems
די סי אס מדיקל בע"מ - רופא - מערכות לאנדוסקופיה
Israeli -
Kiebrania -
Ministry of Health
endoscopy cameras and light sources
די סי אס מדיקל בע"מ - רופא
Israeli -
Kiebrania -
Ministry of Health
טריקסאו אירוספייר
astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate; glycopyrronium - תרחיף לשאיפה - formoterol fumarate dihydrate 5 mcg; glycopyrronium 7.2 mcg; budesonide 160 mcg - budesonide
Israeli -
Kiebrania -
Ministry of Health
ארימידקס
taro international ltd, israel - anastrozole - טבליות מצופות פילם - anastrozole 1.0 mg - anastrozole - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
Israeli -
Kiebrania -
Ministry of Health
ג'בטאנה
sanofi israel ltd - cabazitaxel - תרכיז וממס להכנת תמיסה לאינפוזיה - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen
Israeli -
Kiebrania -
Ministry of Health
דקפפטיל 0.1
ferring pharmaceuticals ltd - triptorelin acetate - תמיסה להזרקה - triptorelin acetate 0.1 mg/ml - triptorelin - triptorelin - precocius puberty, prostatic cancer, endomethriosis, uterus myomatoses and ivf.
Israeli -
Kiebrania -
Ministry of Health
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
Israeli -
Kiebrania -
Ministry of Health
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
Israeli -
Kiebrania -
Ministry of Health
קסאלקורי 250 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
Israeli -
Kiebrania -
Ministry of Health
קסאלקורי 250 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.